These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37586299)

  • 1. Impact of inflammation and anti-inflammatory modalities on diabetic cardiomyopathy healing: From fundamental research to therapy.
    Zhang XJ; Han XW; Jiang YH; Wang YL; He XL; Liu DH; Huang J; Liu HH; Ye TC; Li SJ; Li ZR; Dong XM; Wu HY; Long WJ; Ni SH; Lu L; Yang ZQ
    Int Immunopharmacol; 2023 Oct; 123():110747. PubMed ID: 37586299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy.
    Dhar A; Venkadakrishnan J; Roy U; Vedam S; Lalwani N; Ramos KS; Pandita TK; Bhat A
    Ther Adv Cardiovasc Dis; 2023; 17():17539447231210170. PubMed ID: 38069578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte.
    Filardi T; Ghinassi B; Di Baldassarre A; Tanzilli G; Morano S; Lenzi A; Basili S; Crescioli C
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy.
    Cheng Y; Wang Y; Yin R; Xu Y; Zhang L; Zhang Y; Yang L; Zhao D
    Front Endocrinol (Lausanne); 2023; 14():1162754. PubMed ID: 37065745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
    Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy.
    Zuo G; Ren X; Qian X; Ye P; Luo J; Gao X; Zhang J; Chen S
    J Cell Physiol; 2019 Feb; 234(2):1925-1936. PubMed ID: 30067872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay of inflammation, exosomes and Ca
    Sanganalmath SK; Dubey S; Veeranki S; Narisetty K; Krishnamurthy P
    Cardiovasc Diabetol; 2023 Feb; 22(1):37. PubMed ID: 36804872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
    Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
    Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
    Bulani Y; Sharma SS
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinnamic acid is beneficial to diabetic cardiomyopathy via its cardioprotective, anti-inflammatory, anti-dyslipidemia, and antidiabetic properties.
    Nair A; Preetha Rani MR; Salin Raj P; Ranjit S; Rajankutty K; Raghu KG
    J Biochem Mol Toxicol; 2022 Dec; 36(12):e23215. PubMed ID: 36117386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
    Ding W; Feng H; Li WJ; Liao HH; Zhang N; Zhou ZY; Mou SQ; Lin Z; Xia-He NZ; Xia H; Tang QZ
    Eur J Pharmacol; 2021 Oct; 909():174402. PubMed ID: 34348125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy.
    Zhang L; Ai C; Bai M; Niu J; Zhang Z
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway.
    Li X; Li Z; Li B; Zhu X; Lai X
    Life Sci; 2019 Oct; 234():116773. PubMed ID: 31422095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model.
    Wu B; Huang XY; Li L; Fan XH; Li PC; Huang CQ; Xiao J; Gui R; Wang S
    J Cell Mol Med; 2019 Nov; 23(11):7651-7663. PubMed ID: 31565849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
    Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X
    Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus.
    Graczyk P; Dach A; Dyrka K; Pawlik A
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential Role of Flavonoids in Ameliorating Diabetic Cardiomyopathy via Alleviation of Cardiac Oxidative Stress, Inflammation and Apoptosis.
    Jubaidi FF; Zainalabidin S; Taib IS; Hamid ZA; Budin SB
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
    Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
    Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragalus polysaccharides alleviates cardiac hypertrophy in diabetic cardiomyopathy via inhibiting the BMP10-mediated signaling pathway.
    Sun S; Yang S; Zhang N; Yu C; Liu J; Feng W; Xu W; Mao Y
    Phytomedicine; 2023 Jan; 109():154543. PubMed ID: 36610158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.
    Pang A; Hu Y; Zhou P; Long G; Tian X; Men L; Shen Y; Liu Y; Cui Y
    Cardiovasc Diabetol; 2015 Oct; 14():134. PubMed ID: 26446774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.